BA
ABMD

Bristlecone Advisors’s Abiomed Inc ABMD Stock Holding History

Bristlecone Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,153
Closed -$529K – 260
2022
Q3 		$529K Buy
2,153
+4
+0.2% +$1.08K 0.07% 159
2022
Q2 		$532K Buy
2,149
+312
+17% +$84.2K 0.07% 163
2022
Q1 		$608K Buy
1,837
+110
+6% +$33.9K 0.07% 146
2021
Q4 		$620K Buy
1,727
+282
+20% +$95.3K 0.07% 151
2021
Q3 		$470K Buy
1,445
+104
+8% +$35.2K 0.06% 156
2021
Q2 		$419K Buy
1,341
+14
+1% +$4.29K 0.06% 160
2021
Q1 		$423K Buy
1,327
+77
+6% +$24.6K 0.06% 152
2020
Q4 		$405K Buy
1,250
+149
+14% +$41.2K 0.06% 154
2020
Q3 		$305K Buy
+1,101
New +$317K 0.06% 152

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bristlecone Advisors's ABMD Position: Q4 2022 in Review

Bristlecone Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,153 shares — an estimated $529K sold.

Bristlecone Advisors first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $620K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bristlecone Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bristlecone Advisors sold 2,153 Abiomed Inc shares in Q4 2022, an estimated $529K.
  • Bristlecone Advisors first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • Bristlecone Advisors's Abiomed Inc position peaked at $620K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bristlecone Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.